PXD058734 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Targeted KRAS(G12V) degradation elicits efficient and durable lung adenocarcinoma regression in vivo |
| Description | Recent drug discovery breakthroughs led to the approval of KRASG12C inhibitors in lung adenocarcinoma (LUAD). Unfortunately, clinical responses remain limited due to rapid resistance onset. Proteolysis-targeting chimeras (PROTACs) have emerged as promising alternatives to traditional inhibition. However, there is limited mechanistic understanding of KRAS degradation in vivo. Here, we developed a preclinical LUAD mouse model and demonstrated that targeted KRAS degradation induces rapid tumor regression. Transcriptional and histological analyses revealed a substantial remodeling of the tumor microenvironment. Notably, the low resistance rate observed during long-term treatment stems from proteolysis machinery dysregulation rather than KRAS absence adaptation, indicating resistance mechanisms distinct from KRAS inhibition. Our findings highlight the therapeutic potential of KRAS degradation in LUAD, offering insights into cell-intrinsic and extrinsic mechanisms driving durable antitumor responses and supporting further clinical exploration. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-05-13 |
| AnnouncementXML | Submission_2026-05-13_11:10:42.320.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Marta Vilaseca |
| SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: NEWT:10090; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Orbitrap Eclipse |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2024-12-10 08:06:16 | ID requested | |
| ⏵ 1 | 2026-05-13 11:10:42 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: mouse models,Targeted protein degradation in vivo, resistance, lLung adenocarcinoma, KRAS, PROTACs |
Contact List
| Marta Vilaseca |
| contact affiliation | Mass Spectrometry & Proteomics Core Facility (MSPCF) Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology (BIST) C/ Baldiri Reixac, 10-12 08028 Barcelona - Spain. |
| contact email | masspe@irbbarcelona.org |
| lab head | |
| Marta Vilaseca |
| contact affiliation | Mass Spectrometry & Proteomics Core Facility (MSPCF)
Institute for Research in Biomedicine (IRB Barcelona)
Barcelona Institute of Science and Technology (BIST)
C/ Baldiri Reixac, 10-12
08028 Barcelona - Spain |
| contact email | masspe@irbbarcelona.org |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/05/PXD058734 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD058734
- Label: PRIDE project
- Name: Targeted KRAS(G12V) degradation elicits efficient and durable lung adenocarcinoma regression in vivo